» Articles » PMID: 7978023

Management of Tis, T1, and T2 Squamous Cell Carcinoma of the Glottic Larynx

Overview
Date 1994 Jul 1
PMID 7978023
Citations 9
Authors
Affiliations
Soon will be listed here.
Citing Articles

Metastatic Sarcomatoid Carcinoma of the Larynx: A Case Report.

Derfoufi J, Rezzoug F, Al Jarroudi O, Brahmi S, Afqir S Cureus. 2024; 16(9):e70331.

PMID: 39463652 PMC: 11512813. DOI: 10.7759/cureus.70331.


Organ preservation and oncological outcomes in early laryngeal cancer: a propensity score-based study.

de Carvalho G, Kohler H, de Mello J, Lira R, Pellizzon A, Vartanian J Acta Otorhinolaryngol Ital. 2021; 41(4):317-326.

PMID: 34533535 PMC: 8448187. DOI: 10.14639/0392-100X-N0870.


Influencing Factors on Radiotherapy Outcome in Stage I-II Glottic Larynx Cancer-A Multicenter Study.

Elicin O, Ermis E, Oehler C, Aebersold D, Caparrotti F, Zimmermann F Front Oncol. 2019; 9:932.

PMID: 31616637 PMC: 6763757. DOI: 10.3389/fonc.2019.00932.


Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery.

Ahn S, Hong H, Kwon S, Kwon K, Roh J, Ryu J Clin Exp Otorhinolaryngol. 2017; 10(1):1-43.

PMID: 28043099 PMC: 5327593. DOI: 10.21053/ceo.2016.01389.


Practice variations in voice treatment selection following vocal fold mucosal resection.

Moore J, Rathouz P, Havlena J, Zhao Q, Dailey S, Smith M Laryngoscope. 2016; 126(11):2505-2512.

PMID: 26972900 PMC: 5018919. DOI: 10.1002/lary.25911.